On January 5, Qingfu Capsule, the world's first pure herbal medicine for COVID-19, was jointly developed by China and Belarus and launched in Shanghai. The drug will be produced in the China-Belarus Industrial Park on the outskirts of Minsk, Belarus.

China-belarus Industrial Park Chinese medicine enterprise new era biological medicine company qingfu capsule launch ceremony

  Qingfu Capsule is a pure natural plant extract capsule developed and produced by Dr. CAI Chuanqing of Jintai Cultural Institute of China using modern technology combined with traditional medical essence, which can effectively treat and prevent COVID-19. Since February 2020, Linglan granules have successfully cured COVID-19 patients in many countries, including former Ukrainian Prime Minister Yulia Tymoshenko and president Petro Poroshenko, as well as in China, Russia, Switzerland, Ukraine, Dominica, the United States and Ghana. On the basis of Linglan Qingqing granules, Dr. CAI Chuanqing developed a qingqing capsule more in line with The customs of Europe and the United States by combining modern pharmaceutical technology. On October 14, 2021, the capsule was approved for emergency use by the Ministry of Health of Belarus and became an important strategic drug in Belarus.

The world's first pure herbal medicine for COVID-19, jointly developed by China and Belarus, has been released

  In recent years, China and Belarus have carried out many practices in promoting exchanges and cooperation in the field of traditional medicine. Belarus has a unique folk medicine tradition and rich local medicinal plant resources, offering broad prospects for bilateral cooperation in traditional medicine.

  With the support of the two governments, the China-Belarus Industrial Park has gradually become an industrial gathering platform for the two countries to expand regional cooperation and economic and trade exchanges, as well as an international production capacity cooperation and technological innovation platform under the Belt and Road Initiative. Up to now, 80 enterprises have entered the park.

  "TCM is now known as an effective means in the prevention and treatment of COVID-19." Speaking at the press conference, Nikolai Snopkov, first Deputy Prime Minister of Belarus, said that the Ministry of Health of Belarus registered the clear capsule in a very short period of time and listed it as an important strategic drug for the prevention and treatment of COVID-19 in Belarus.

  In June 2021, the Republic of Belarus signed a presidential decree on improving business conditions in the China-Belarus Industrial Park. According to the presidential decree, in the China-Belarus Industrial Park, enterprises can use traditional Chinese medicine to provide medical services without having to go through the mandatory registration of Belarus and obtaining the license for medical activities.

  "Today's TCM is an organic combination of tradition and innovation, attracting the attention of more and more countries and people around the world." Belarusian Ambassador to China Yuri Shenko believes that with the support of the belarusian and Chinese governments, the TCM project will surely develop well and further explore the two major markets of Eurasian Economic Union and EU.

  "Traditional Chinese medicine belongs to Both China and the world." Ren Hongbin, deputy director of The State-owned Assets Supervision and Administration Commission of the State Council of China, said in his speech that he hoped more enterprises of the two countries could rely on the china-Belarus Industrial Park platform to realize complementary advantages in capital, technology, products and markets and make positive contributions to bilateral economic and trade cooperation and high-quality development.